|drug4138||telephone consult Wiki||1.00|
|drug2595||Positive Emotion Skills Course Wiki||1.00|
There is one clinical trial.
trial to assess the effectiveness of pre-operative screening for COVID-19 in patients undergoing elective cancer surgery.
Description: Diagnosis of COVID on day of surgery (based on Clinical symptoms +/- positive swab diagnosis)Measure: diagnosis of COVID before surgery Time: prior to surgery
Description: Diagnosis by day 14 (+/-2) post-surgery (based on Clinical symptoms from inpatient notes or telephone consultation +/- positive swab diagnosis)Measure: diagnosis of COVID after surgery Time: 14 days post op
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports